임상시험 장비 및 보조 솔루션 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 단계별, 지역별, 부문별 예측(2024-2030년)

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics, Service, Others), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,185,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,561,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,312,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

임상시험 장비 및 보조 솔루션 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 임상시험 장비 및 보조 솔루션 시장 규모는 2024년부터 2030년까지 연평균 8.1%의 연평균 복합 성장률(CAGR)로 확대되어 2030년에는 51억 달러에 달할 것으로 예상됩니다.

제약 및 의료 분야의 성장, 임상시험의 세계화, R&D 비용 증가가 시장을 견인하는 요인입니다. 그러나 코로나19 팬데믹은 전 세계 시장에 영향을 미치고 있으며, 그 결과 장비 및 보조용품 공급망이 둔화되고 있습니다. 코로나19 팬데믹은 임상시험 환경에 큰 변화를 가져왔으며, 코로나19 팬데믹으로 인해 전 세계적으로 임상시험이 중단되었습니다. 이전에는 수백 개의 임상시험이 진행 중이었습니다. 그러나 새롭고 더 나은 치료법에 대한 수요가 증가함에 따라 팬데믹 이후 임상시험의 수가 증가했습니다.

임상시험 절차는 최근 몇 년동안 상당히 발전했습니다. 복잡한 임상시험은 헬스케어 공급망 전반에 걸쳐 새로운 문제를 야기하고 있습니다. 최신 연구에는 수많은 환자와 환자 하위 그룹, 그리고 수많은 국가와 연구기관이 참여하는 경우가 많습니다. 그 결과, 공급망 관리자들이 임상시험 장비 및 부대시설과 관련하여 직면하는 문제가 증가하고 있습니다. 의료기기 렌탈은 보관, 회수 및 폐기 부담을 줄여줍니다. 또 다른 중요한 의사 결정의 이유는 장비 대여를 통해 허가된 임상시험 실시 장소에 필요한 막대한 초기 비용과 막대한 투자를 줄일 수 있다는 점입니다.

코로나19로 인해 효과적인 치료법과 중재에 대한 요구가 생겨났고, 코로나19는 임상시험 수행 방식을 변화시켜 헬스케어의 디지털화와 첨단 기술 및 방법론의 채택을 촉진하고 있습니다. 이러한 채택은 시장 성장을 가속할 것으로 보입니다. 또한, 코로나19의 혁신적인 치료법을 개발하기 위해 제약회사들이 높은 R&D 비용을 투자하고 있는 것도 시장 성장에 더욱 기여하고 있습니다.

임상시험 장비 및 보조 솔루션 시장 보고서 하이라이트

• 공급/물류 제품 부문은 전 세계적으로 많은 임상시험과 효율적인 물류 서비스에 대한 수요 증가로 인해 2023년 38.95% 이상의 매출 점유율을 차지하며 시장을 장악했습니다.
• 3상 부문은 2023년에 시장을 장악하고 2030년까지 그 우위를 유지할 것으로 예상됩니다. 임상 3상 시험은 새로운 치료 표준을 발견하는 가장 효과적인 접근 방식입니다.
• 북미는 2022년 세계 시장을 주도할 것으로 예상되며, 이 지역의 CRO와 제약 및 의료 기업 증가로 인해 예측 기간 동안에도 우위를 유지할 것으로 보입니다.
• 아태지역은 임상시험 실시 장소로 점점 더 중요성이 높아지면서 예측 기간 동안 임상시험 장비 및 부대 솔루션 시장에서 가장 빠른 성장을 보일 전망입니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 임상시험 장비 및 보조 솔루션 시장 변수, 동향 및 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/보조적인 시장 전망.
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 임상시험 장비 및 보조 솔루션 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 임상시험 장비 및 보조 솔루션 시장 : 제품 추정·동향 분석

• 제품 시장 점유율, 2023년과 2030년
• 부문 대시보드
• 세계의 임상시험 장비 및 보조 솔루션 시장, 제품 전망 별
• 시장 규모, 예측 및 동향 분석, 2018-2030년
  • 소싱
  • 공급/물류
  • 서비스
  • 기타

제5장 임상시험 장비 및 보조 솔루션 시장 : 단계 추정·동향 분석

• 단계 시장 점유율, 2023년 및 2030년
• 부문 대시보드
• 세계의 임상시험 장비 및 보조 솔루션 시장, 단계별 전망
• 시장 규모, 예측 및 동향 분석, 2018-2030년
  • 단계 1
  • 단계 2
  • 단계 3
  • 단계 4
  • 기타

제6장 임상시험 장비 및 보조 솔루션 시장 : 지역 추정·동향 분석

• 지역 시장 점유율 분석, 2023년 및 2030년
• 지역 시장 대시보드
• 세계의 지역 시장 스냅숏
• 시장 규모와 예측 및 동향 분석 (2018-2030년)
• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 진출기업의 최근 동향과 영향 분석
• 예측 기간 동안 연평균 복합 성장률(CAGR)
• 벤더 구도
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
  • Ancillare, LP
  • Imperial CRS, Inc.
  • Woodley Equipment Company Ltd.
  • Thermo Fisher Scientific, Inc.
  • Parexel International(MA) Corporation
  • Emsere(MediCapital Rent)
  • Quipment SAS
  • IRM
  • Marken
  • Myonex
  • Yourway

LSH

영문 목차

영문목차

Clinical Trial Equipment & Ancillary Solutions Market Growth & Trends:

The global clinical trial equipment & ancillary solutions market size is expected to reach USD 5.10 billion by 2030, expanding at a CAGR of 8.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market. However, the COVID-19 pandemic has affected the global market, which resulted in slowing down the supply chain of equipment & ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments were in progress before the pandemic was halted due to COVID-19 globally. However, the growing demand for new and better treatment options has improved the number of clinical trial in the post-pandemic.

The clinical trial procedure has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve huge numbers of patients and patient subgroups, as well as numerous nations and research sites. As a result, the number of challenges that supply chain managers confront while working with clinical trial equipment & ancillaries has increased. Renting medical equipment relieves the burden of storage, retrieval, and disposal. Another important decision-making reason is that renting equipment reduces significant upfront expenses and large investments required to furnish licensed clinical trial locations.

The pandemic has created a need for effective therapies and interventions. COVID-19 has changed the way clinical trials are conducted, encouraging the digitization of healthcare and the adoption of cutting-edge technologies and techniques. Such adoptions are likely to propel market growth. Moreover, the high R&D spending by the pharmaceutical company for developing innovative therapies for COVID-19 has further contributed to the market growth.

Clinical Trial Equipment & Ancillary Solutions Market Report Highlights:

• The supply/logistics product segment dominated the market with a revenue share of more than 38.95% in 2023 due to the high number of clinical trials globally, which resulted in increased demand for efficient logistics services
• The phase III segment dominated the market in 2023 and is expected to maintain its dominance through 2030. Phase III studies are the most effective approach to discovering a new treatment standard
• North America led the global market in 2022 and is expected to remain dominant even during the forecast years due to a rise in the number of CRO and pharmaceutical & medical companies in the region
• Asia Pacific is anticipated to witness fastest growth in the clinical trial equipment and ancillary solutions market during the forecast period as it is becoming an increasingly significant site for clinical trial investigations

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Phase
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Phase outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Trial Equipment & Ancillary Solutions Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Evolving Clinical Trials Needs
    • 3.2.1.2. Rising Investment in R&D
    • 3.2.1.3. Growing pharmaceutical & Medical Devices industry
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Rising Cost of Clinical Trials
• 3.3. Clinical Trial Equipment & Ancillary Solutions Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
  • 3.3.2. PESTEL Analysis

Chapter 4. Clinical Trial Equipment & Ancillary Solutions Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Clinical Trial Equipment & Ancillary Solutions Market, by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following:
  • 4.4.1. Sourcing
    • 4.4.1.1. Sourcing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2. Procurement
    • 4.4.1.2.1. Procurement market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2.2. Equipment
    • 4.4.1.2.2.1. Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2.3. Ancillaries
    • 4.4.1.2.3.1. Ancillaries market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.3. Rental
    • 4.4.1.3.1. Rental market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.3.1.1. Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.3.2. Ancillaries
    • 4.4.1.3.2.1. Ancillaries market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Supply/ Logistics
    • 4.4.2.1. Supply/logistics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.2. Transportation
    • 4.4.2.2.1. Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.3. Packaging
    • 4.4.2.3.1. Packaging market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.4. Others
    • 4.4.2.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Service
    • 4.4.3.1. Service market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.2. Calibrations
    • 4.4.3.2.1. Calibrations market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.3. Equipment Servicing
    • 4.4.3.3.1. Equipment servicing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.4. Others
    • 4.4.3.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis

• 5.1. Phase Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Clinical Trial Equipment & Ancillary Solutions Market, by Phase Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following:
  • 5.4.1. Phase I
    • 5.4.1.1. Phase I market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Phase II
    • 5.4.2.1. Phase II market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Phase III
    • 5.4.3.1. Phase III market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Phase IV
    • 5.4.4.1. Phase IV market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Equipment & Ancillary Solutions Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. Mexico
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. Colombia
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive scenario
    • 6.8.4.4. Colombia market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Ancillare, LP
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Imperial CRS, Inc.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Woodley Equipment Company Ltd.
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Thermo Fisher Scientific, Inc.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Parexel International (MA) Corporation
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Emsere (MediCapital Rent)
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Quipment SAS
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. IRM
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Marken
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Myonex
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. Yourway
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives

관련자료